Filter posts

The Latest Good News on Prescription Drug Costs

Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These …

Fact Checking Misleading Claims about Drug Costs

In a series of new blogs, AHIP once again paints drug manufacturers as the culprit …

A New Framework for Evaluating – and Encouraging – Industry’s IP-Sharing Activities for Global...

The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to …

One Health: Biotechnology Sector Ready to Act

Globalization has changed our models of disease. Emerging health threats throughout the world have the …

ICYMI: 340B: Good Intentions, Wrong Path

It’s been 25 years since Congress created the 340B Drug Discount Program – a program …

President’s Cancer Panel Recommends Shift Towards Value

This week, the President’s Cancer Panel published a new report entitled “Promoting Value, Affordability, and …

ICER Comes Under Renewed Scrutiny

As we enter a new and exciting era of medicine, there is an important question …

Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs

This week, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. …

Preparing for the Next Public Health Emergency

The weather report shows a 50 percent chance of rain tomorrow. Should you pack an …

Secretary Azar Talks Opioid Strategy with NGA

Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and …